Suchergebnisse - "Cook, Gordon"

PubPharm (44)

1

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial

enthalten in: British journal of haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +16

2

Optimizing the value of lenalidomide maintenance by extended genetic profiling : an analysis of 556 patients in the Myeloma XI trial

enthalten in: Blood | 2023

von Panopoulou, A. | Cairns, D. | Holroyd, A. | +13

CommentIn: Blood. 2023 Apr 6;141(14):1649-1650. - PMID 37022733

3

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma : frailty subgroup analysis of MAIA

enthalten in: Leukemia | 2022

von Facon, T. | Cook, G. | Usmani, S. | +25

4

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma : MUKeight phase II randomised controlled trial results

enthalten in: Blood cancer journal | 2022

von Auner, H. | Brown, S. | Walker, K. | +9

5

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

enthalten in: Blood | 2022

von San-Miguel, J. | Avet-Loiseau, H. | Paiva, B. | +24

CommentIn: Blood. 2022 Jan 27;139(4):469-471. - PMID 35084473

6

Autologous stem cell transplantation is safe and effective for fit older myeloma patients : exploratory results from the Myeloma XI trial

enthalten in: Haematologica | 2022

von Pawlyn, C. | Cairns, D. | Menzies, T. | +11

7

Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes : Results from 3894 Patients in the Myeloma XI Trial

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Bird, S. | Cairns, D. | Menzies, T. | +12

8

Health-related quality of life in patients with relapsed or refractory multiple myeloma : treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

enthalten in: British journal of haematology | 2021

von Plesner, T. | Dimopoulos, M. | Oriol, A. | +15

9

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

enthalten in: Haematologica | 2021

von Jackson, G. | Davies, F. | Pawlyn, C. | +21

10

Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma

enthalten in: British journal of haematology | 2021

von Bygrave, C. | Pawlyn, C. | Davies, F. | +11

1
2
3
4
5
Nächster »
[5]